CIK 0001178253 · Non-accelerated filer<br>Smaller reporting company
SCYNEXIS INC
Sign in to watch- Ticker
- SCYX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 562181648
- Phone
- 201-884-5485
- Business address
- 1 EVERTRUST PLAZA, 13TH FLOOR, JERSEY CITY, NJ, 07302-6548
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-18 | Burke Steven Keith Director | Grant or award | +5,750 | 5,750 | ||
| 2026-09-18 | Burke Steven Keith Director | Grant or award · Stock Option (Right to Buy) | +5,750 | 5,750 | ||
| 2026-09-09 | Subramanian Sanjay Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2026-06-26 | Tinmouth Brian Philippe Director | Grant or award | +2,875 | 12,125 | ||
| 2026-06-26 | Tinmouth Brian Philippe Director | Grant or award · Stock Option (Right to Buy) | +2,875 | 2,875 | ||
| 2026-06-26 | Macdonald Guy Director | Grant or award | +2,875 | 12,625 | ||
| 2026-06-26 | Macdonald Guy Director | Grant or award · Stock Option (Right to Buy) | +2,875 | 2,875 | ||
| 2026-06-26 | HANHAM ANN Director | Grant or award | +2,875 | 11,577 | ||
| 2026-06-26 | HANHAM ANN Director | Grant or award · Stock Option (Right to Buy) | +2,875 | 2,875 | ||
| 2026-06-26 | HASTINGS DAVID C Director | Grant or award | +2,875 | 11,522 | ||
| 2026-06-26 | HASTINGS DAVID C Director | Grant or award · Stock Option (Right to Buy) | +2,875 | 2,875 | ||
| 2026-06-26 | ANIDO ARMANDO Director | Grant or award | +2,875 | 11,750 | ||
| 2026-06-26 | ANIDO ARMANDO Director | Grant or award · Stock Option (Right to Buy) | +2,875 | 2,875 | ||
| 2026-04-01 | Angulo Gonzalez David Chief Executive Officer | Purchase | +108,695 | 1,357,126 | ||
| 2026-04-01 | Angulo Gonzalez David Chief Executive Officer | Purchase · Warrant to Purchase Common Stock | +108,695 | 108,695 | ||
| 2026-01-29 | Sukenick Scott Chief Legal Officer | Grant or award | +129,833 | 574,539 | ||
| 2026-01-29 | Macleod ivor Chief Financial Officer | Grant or award | +129,833 | 398,529 | ||
| 2026-01-29 | Angulo Gonzalez David Chief Executive Officer | Grant or award | +391,333 | 1,244,431 | ||
| 2025-10-17 | Angulo Gonzalez David Chief Executive Officer | Grant or award | +32,500 | $0.76 | $25K | 853,098 |
| 2025-06-26 | Tinmouth Brian Philippe Director | Grant or award | +23,000 | 74,000 |
Page 1 of 9 · 165 trades